The influence of SARS-CoV-2 co-infection and active tuberculosis on the severity of the disease course and mortality.

G. Przybylski (Osielsko, Poland), A. Kozanecka (Bydgoszcz, Poland), M. Pilaczynska-Cemel (Bydgoszcz, Poland)

Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Session: Tuberculosis, COVID-19 and other comorbidities
Session type: E-poster
Number: 1030

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Przybylski (Osielsko, Poland), A. Kozanecka (Bydgoszcz, Poland), M. Pilaczynska-Cemel (Bydgoszcz, Poland). The influence of SARS-CoV-2 co-infection and active tuberculosis on the severity of the disease course and mortality.. 1030

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Influence of disease severity and comorbidity on mortality rate in tuberculosis
Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups
Year: 2008


Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease
Source: Eur Respir J, 51 (1) 1701578; 10.1183/13993003.01578-2017
Year: 2018



The effect of hospitalization and disease itself on smoking sessation of patients with tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 155s
Year: 2004

The effect of alcohol use on course of tuberculosis disease
Source: Annual Congress 2003 - Clinical aspects of tuberculosis
Year: 2003


Pulmonary function after COVID-19 infection and the impact of disease severity.
Source: Virtual Congress 2021 – Respiratory function after COVID-19 and mechanical ventilation
Year: 2021



The definition of tuberculosis infection based on the spectrum of tuberculosis disease
Source: Breathe, 17 (3) 1900655; 10.1183/20734735.0079-2021
Year: 2021



The prevalence of latent pulmonary tuberculosis infection (LTBI) in low and high risk populations in Ireland
Source: Eur Respir J 2005; 26: Suppl. 49, 425s
Year: 2005

Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands
Source: Eur Respir J 2016; 48: 1420-1428
Year: 2016



The risk of tuberculosis disease among HIV infected patients after 2 years of follow up
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011

Identification of high risk factors for development of active tuberculosis in children with latent tuberculosis infections
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017


A study of prevalence of depression in patients with multi drug resistant tuberculosis
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016


Does the clinical symptoms of drug resistant pulmonary tuberculosis (PTB) act as a predictor in HIV non-infected/infected patient? An Indian scenario
Source: Eur Respir J 2006; 28: Suppl. 50, 858s
Year: 2006

Does the radiological manifestation of drug resistant pulmonary tuberculosis (PTB) in HIV non-infected/infected patients differ – an Indian picture
Source: Eur Respir J 2007; 30: Suppl. 51, 440s
Year: 2007

Site of active tuberculosis disease predicts survival in HIV-associated tuberculosis
Source: Annual Congress 2010 - Tuberculosis and HIV coinfection
Year: 2010



The dynamics of tuberculosis incidence and diagnostics of latent tuberculosis tuberculosis infection in children of Ukraine.
Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people
Year: 2018

Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment
Source: Eur Respir J 2003; 21: 478-482
Year: 2003



Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1594-1595
Year: 2016


Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1592-1594
Year: 2016


Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2015; 46: 1397-1406
Year: 2015



Prevalence of CNS lesions in patients with pulmonary tuberculosis and HIV infection
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019